Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: Comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. the InSync/InSync ICD Italian Registry

European Heart Journal

Volumn 30, Issue 18, 2009, Pages 2275-2283

  Boriani, Giuseppe ^a   Gasparini, Maurizio ^b   Landolina, Maurizio ^c   Lunati, Maurizio ^d   Biffi, Mauro ^a   Santini, Massimo ^e   Padeletti, Luigi ^f   Molon, Giulio ^g   Botto, Gianluca ^h   De Santo, Tiziana ⁱ   Valsecchi, Sergio ⁱ  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^h SANT ANNA HOSPITAL   (Italy)

ⁱ Medtronic Italia   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Remodelling; Valvular heart disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; REGISTRIES; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 70349463026     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp226     Document Type: Article

References (19)

1. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation 2000;102:1076-1078.
2. Tavazzi L. Ventricular pacing: a promising new therapeutic strategy in heart failure. For whom? Eur Heart J 2000;21:1211-1214.
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
4. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
7. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, Pini D, Ceriotti C, Gronda E, Klersy C, Fratini S, Klein HH. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-743.
8. Gasparini M, Auricchio A, Metra M, Regoli F, Fantoni C, Lamp B, Curnis A, Vogt J, Klersy C, Multicentre Longitudinal Observational Study (MILOS) Group. Longterm survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008;29:1644-1652.
9. Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, Gorcsan J III, Hayes DL, Kass DA, Knuuti J, Leclercq C, Linde C, Mark DB, Monaghan MJ, Nihoyannopoulos P, Schalij MJ, Stellbrink C, Yu CM. Cardiac resynchronization therapy: Part 2-issues during and after device implantation and unresolved questions. J Am Coll Cardiol 2005;46:2168-2182.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
11. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7: 176-182.
12. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-464.
13. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007;297: 2502-2514. (Pubitemid 46953404)
14. Mac?́as A, Gavira JJ, Castaño S, Moreno J, Alegr?́a E, Garc?́a-Bolao I. Cardiac resynchronization therapy and valvular cardiomyopathy after corrective surgery. Rev Esp Cardiol 2008;61:1088-1091.
15. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M, Clementy J. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002;89: 346-350.
16. Mangiavacchi M, Gasparini M, Faletra F, Klersy C, Morenghi E, Galimberti P, Genovese L, Regoli F, De Chiara F, Bragato R, Andreuzzi B, Pini D, Gronda E. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. Am Heart J 2006;151:477.e1-477
17. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006;113:266-272.
18. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868.
19. Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2006;98:230-235.